+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 76 Pages
  • Asia Pacific
From
North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 70 Pages
  • North America
From
Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 90 Pages
  • Middle East, Africa
From
South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 55 Pages
From
Japan Antiplatelet Drugs Market Report and Forecast 2025-2034 - Product Thumbnail Image

Japan Antiplatelet Drugs Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 250 Pages
  • Japan
From
Hyperphosphatemia Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hyperphosphatemia Drugs Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Europe Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Europe Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Europe
From
North America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

North America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 120 Pages
  • North America
From
Middle East and Africa Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Middle East and Africa Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Africa, Middle East
From
Latin America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
Cold Agglutinin Disease Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cold Agglutinin Disease Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Iron Deficiency Anaemia Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Iron Deficiency Anaemia Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
VONVENDI Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

VONVENDI Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 140 Pages
  • Global
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 - Product Thumbnail Image

Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

  • Drug Pipelines
  • March 2023
  • 150 Pages
  • Global
From
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 77 Pages
  • Global
From
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 182 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Chronic Kidney Disease Anemia - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Chronic Kidney Disease Anemia - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 130 Pages
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more